Novel mutation in Sjögren-Larsson syndrome is associated with divergent neurologic phenotypes

Kathleen Davis, Kenton R. Holden, Dana S'Aulis, Claudia Amador, M. Gisele Matheus, William B Rizzo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Sjögren-Larsson syndrome is an inherited disorder of lipid metabolism caused by mutations in the ALDH3A2 gene that codes for fatty aldehyde dehydrogenase, which results in accumulation of fatty aldehydes and alcohols and is characterized by ichthyosis, intellectual disability, and spastic diplegia/quadriplegia. The authors describe 2 unrelated Honduran patients who carried the same novel homozygous nonsense mutation (c.1309A>T, p.K437X) and ALDH3A2 DNA haplotype, but widely differed in disease severity. One patient exhibited spastic quadriplegia with unusual neuroregression, whereas the other patient had the usual static form of spastic diplegia with neurodevelopmental disabilities. Biochemical analyses showed a similar profound deficiency of fatty aldehyde dehydrogenase activity and impaired fatty alcohol metabolism in both patients' cultured fibroblasts. These results indicate that variation in the neurologic phenotype of Sjögren-Larsson syndrome is not strictly determined by the ALDH3A2 mutation or the biochemical defect as expressed in cultured fibroblasts, but by unidentified epigenetic/environmental factors, gene modifiers, or other mechanisms.

Original languageEnglish (US)
Pages (from-to)1259-1265
Number of pages7
JournalJournal of Child Neurology
Volume28
Issue number10
DOIs
StatePublished - Oct 1 2013

Fingerprint

Nervous System
Fatty Alcohols
Phenotype
Mutation
long-chain-aldehyde dehydrogenase
Quadriplegia
Cerebral Palsy
Sjogren-Larsson Syndrome
Fibroblasts
Lipid Metabolism Disorders
Modifier Genes
Ichthyosis
Nonsense Codon
Epigenomics
Intellectual Disability
Haplotypes
DNA
Genes

Keywords

  • Sjögren-Larsson
  • aldehyde dehydrogenase
  • fatty alcohol
  • ichthyosis
  • mutation
  • neurologic
  • phenotype
  • spasticity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Novel mutation in Sjögren-Larsson syndrome is associated with divergent neurologic phenotypes. / Davis, Kathleen; Holden, Kenton R.; S'Aulis, Dana; Amador, Claudia; Matheus, M. Gisele; Rizzo, William B.

In: Journal of Child Neurology, Vol. 28, No. 10, 01.10.2013, p. 1259-1265.

Research output: Contribution to journalArticle

Davis, Kathleen ; Holden, Kenton R. ; S'Aulis, Dana ; Amador, Claudia ; Matheus, M. Gisele ; Rizzo, William B. / Novel mutation in Sjögren-Larsson syndrome is associated with divergent neurologic phenotypes. In: Journal of Child Neurology. 2013 ; Vol. 28, No. 10. pp. 1259-1265.
@article{ca227c745d824e0b90ef0a0489dd6e94,
title = "Novel mutation in Sj{\"o}gren-Larsson syndrome is associated with divergent neurologic phenotypes",
abstract = "Sj{\"o}gren-Larsson syndrome is an inherited disorder of lipid metabolism caused by mutations in the ALDH3A2 gene that codes for fatty aldehyde dehydrogenase, which results in accumulation of fatty aldehydes and alcohols and is characterized by ichthyosis, intellectual disability, and spastic diplegia/quadriplegia. The authors describe 2 unrelated Honduran patients who carried the same novel homozygous nonsense mutation (c.1309A>T, p.K437X) and ALDH3A2 DNA haplotype, but widely differed in disease severity. One patient exhibited spastic quadriplegia with unusual neuroregression, whereas the other patient had the usual static form of spastic diplegia with neurodevelopmental disabilities. Biochemical analyses showed a similar profound deficiency of fatty aldehyde dehydrogenase activity and impaired fatty alcohol metabolism in both patients' cultured fibroblasts. These results indicate that variation in the neurologic phenotype of Sj{\"o}gren-Larsson syndrome is not strictly determined by the ALDH3A2 mutation or the biochemical defect as expressed in cultured fibroblasts, but by unidentified epigenetic/environmental factors, gene modifiers, or other mechanisms.",
keywords = "Sj{\"o}gren-Larsson, aldehyde dehydrogenase, fatty alcohol, ichthyosis, mutation, neurologic, phenotype, spasticity",
author = "Kathleen Davis and Holden, {Kenton R.} and Dana S'Aulis and Claudia Amador and Matheus, {M. Gisele} and Rizzo, {William B}",
year = "2013",
month = "10",
day = "1",
doi = "10.1177/0883073812460581",
language = "English (US)",
volume = "28",
pages = "1259--1265",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "10",

}

TY - JOUR

T1 - Novel mutation in Sjögren-Larsson syndrome is associated with divergent neurologic phenotypes

AU - Davis, Kathleen

AU - Holden, Kenton R.

AU - S'Aulis, Dana

AU - Amador, Claudia

AU - Matheus, M. Gisele

AU - Rizzo, William B

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Sjögren-Larsson syndrome is an inherited disorder of lipid metabolism caused by mutations in the ALDH3A2 gene that codes for fatty aldehyde dehydrogenase, which results in accumulation of fatty aldehydes and alcohols and is characterized by ichthyosis, intellectual disability, and spastic diplegia/quadriplegia. The authors describe 2 unrelated Honduran patients who carried the same novel homozygous nonsense mutation (c.1309A>T, p.K437X) and ALDH3A2 DNA haplotype, but widely differed in disease severity. One patient exhibited spastic quadriplegia with unusual neuroregression, whereas the other patient had the usual static form of spastic diplegia with neurodevelopmental disabilities. Biochemical analyses showed a similar profound deficiency of fatty aldehyde dehydrogenase activity and impaired fatty alcohol metabolism in both patients' cultured fibroblasts. These results indicate that variation in the neurologic phenotype of Sjögren-Larsson syndrome is not strictly determined by the ALDH3A2 mutation or the biochemical defect as expressed in cultured fibroblasts, but by unidentified epigenetic/environmental factors, gene modifiers, or other mechanisms.

AB - Sjögren-Larsson syndrome is an inherited disorder of lipid metabolism caused by mutations in the ALDH3A2 gene that codes for fatty aldehyde dehydrogenase, which results in accumulation of fatty aldehydes and alcohols and is characterized by ichthyosis, intellectual disability, and spastic diplegia/quadriplegia. The authors describe 2 unrelated Honduran patients who carried the same novel homozygous nonsense mutation (c.1309A>T, p.K437X) and ALDH3A2 DNA haplotype, but widely differed in disease severity. One patient exhibited spastic quadriplegia with unusual neuroregression, whereas the other patient had the usual static form of spastic diplegia with neurodevelopmental disabilities. Biochemical analyses showed a similar profound deficiency of fatty aldehyde dehydrogenase activity and impaired fatty alcohol metabolism in both patients' cultured fibroblasts. These results indicate that variation in the neurologic phenotype of Sjögren-Larsson syndrome is not strictly determined by the ALDH3A2 mutation or the biochemical defect as expressed in cultured fibroblasts, but by unidentified epigenetic/environmental factors, gene modifiers, or other mechanisms.

KW - Sjögren-Larsson

KW - aldehyde dehydrogenase

KW - fatty alcohol

KW - ichthyosis

KW - mutation

KW - neurologic

KW - phenotype

KW - spasticity

UR - http://www.scopus.com/inward/record.url?scp=84884192623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884192623&partnerID=8YFLogxK

U2 - 10.1177/0883073812460581

DO - 10.1177/0883073812460581

M3 - Article

C2 - 23034980

AN - SCOPUS:84884192623

VL - 28

SP - 1259

EP - 1265

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 10

ER -